AdipoPharma SAS

AdipoPharma

This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.

Adipo Therapeutics

This biopharmaceutical company develops Notch-inhibiting nanoparticle therapies that convert white fat into energy-burning brown fat for patients with obesity and Type 2 diabetes.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

Antag Therapeutics

This company develops GIP receptor antagonist therapies to treat patients living with obesity, type 2 diabetes and metabolic disorders.

Zealand Pharma

This biotechnology company develops peptide-based medicines for patients with obesity, rare diseases and chronic inflammation through metabolic health research.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Adiposs

This biotech company develops medical imaging contrast agents to detect early-stage body wasting for cancer and chronic disease patients.

GutCRINE

This company develops microbiome-derived pharmabiotics to treat metabolic and age-related disorders including obesity and type-2 diabetes for patients with chronic diseases.